{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:13:35Z","timestamp":1790374415783,"version":"4.1.0"},"reference-count":5,"publisher":"BMJ","issue":"e3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2023,4,20]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Elevated cortisol by adrenocortical carcinoma leads to a variety of symptoms. We report on the efficacy of metyrapone in treatment of a variety of distressing symptoms caused by elevated cortisol in a patient who refused advanced treatment for adrenocortical carcinoma.<\/jats:p>","DOI":"10.1136\/spcare-2023-004233","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:22:44Z","timestamp":1683048164000},"page":"e971-e973","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of metyrapone for symptoms of adrenocortical carcinoma"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7883-3940","authenticated-orcid":false,"given":"Yuka","family":"Okuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"2024121022580621000_13.e3.e971.1","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical Carcinomas and malignant Phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Annals of oncology"},{"key":"2024121022580621000_13.e3.e971.2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2014.05.009","article-title":"Adrenocortical carcinoma: The management of metastatic disease","volume":"92","author":"Fay","year":"2014","journal-title":"Critical reviews in oncology\/hematology"},{"key":"2024121022580621000_13.e3.e971.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818"},{"key":"2024121022580621000_13.e3.e971.4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12020-017-1428-9","article-title":"Adding Metyrapone to chemotherapy plus Mitotane for Cushing's syndrome due to advanced Adrenocortical carcinoma","volume":"61","author":"Claps","year":"2018","journal-title":"Endocrine"},{"key":"2024121022580621000_13.e3.e971.5","unstructured":"Committee for the preparation of a guideline for the prevention and treatment of osteoporosis . A guideline for the prevention and treatment of osteoporosis. Tokyo: Life Science Publishing Co., Ltd, 2015."}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2023-004233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:18:34Z","timestamp":1733901514000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2023-004233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":5,"journal-issue":{"issue":"e3","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/spcare-2023-004233"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2023-004233","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]}}}